New study could inform treatment and prevent heart attack in diabetic patients

L-R: Dr Yung Chih Chen, Professor Karin Jandeleit-Dahm
and Professor Karlheinz Peter

A new study by researchers at the Baker Heart and Diabetes Institute and Monash University could help inform treatment and prevent serious events such as a heart attack or death in diabetic patients at high risk of serious cardiovascular events.

The chilling links between diabetes and cardiovascular disease are clear, and this latest study shows, for the first time, the potential of the SGLT2 inhibitor, dapagliflozin, to stabilise vulnerable plaque in patients with diabetes to prevent plaque rupture and a heart attack.